AVAC Think-Tank on Intermittent Dosing of PrEP
December 20, 2008In December 2008, AVAC held a one-day think tank where colleagues from multiple agencies and research disciplines discussed key scientific questions to be addressed in evaluating the merits of future prevention research on intermittent use of pre-exposure prophylaxis ("iPrEP") for prevention of HIV.
- Download the meeting summary for Trials of Intermittent Dosing of Pre-Exposure Prophylaxis (PrEP) - Preparing for PrEP: Policy, Practice and Politics




